High-throughput screening and clinical importance of autophagy-associated genes in basal cell carcinoma

Saffet Ulutas1, Mehmet Mutaf1, Mustafa Nihat Koc1

  • 1Department of Plastic and Reconstructive Surgery, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey.

PubMed

Insights

Autophagy is crucial for cell health and cancer. This study found Interferon Alpha 2 (IFNA2) gene expression significantly changes in basal cell carcinoma, suggesting its role in cancer development and potential therapeutic targeting.

Area of Science:

  • Cellular biology
  • Molecular oncology
  • Dermatology

Background:

  • Autophagy is a key cellular process for maintaining homeostasis and is implicated in various cancers.
  • The role of autophagy in non-melanoma skin cancers, specifically basal cell carcinoma (BCC), is not well understood.
  • Understanding autophagy's role in BCC is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the role of autophagy-associated signaling in basal cell carcinoma (BCC) development and progression.
  • To identify specific autophagy-related genes altered in BCC.
  • To explore the potential of these genes as therapeutic targets.

Main Methods:

  • Screening of 72 autophagy-related genes using high-throughput quantitative PCR (qPCR).
  • Utilized Fluidigm 96.96 Dynamic Array™ integrated fluidic circuits (IFC) and BioMark™ HD Real-Time PCR system for gene expression analysis.
  • Statistical analysis of gene expression data using Fluidigm's Real-Time PCR Analysis software and the 2-ΔΔCt method.

Main Results:

  • Expression levels of INS, TMEM74, and IFNA2 genes were altered in BCC compared to healthy tissues.
  • Interferon Alpha 2 (IFNA2) gene expression showed a statistically significant change in BCC.
  • These findings highlight potential alterations in autophagy signaling pathways within BCC.

Conclusions:

  • IFNA2 may play a significant role in the regulation of autophagy during BCC development and progression.
  • IFNA2 represents a potential therapeutic target for basal cell carcinoma.
  • Further research into IFNA2's function in BCC is warranted.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.3K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K